Delpha Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Delpha Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$264K	Buy	+6,683	New	+$260K	0.36%	92

Other funds holding ARNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Delpha Capital Management's ARNA Position: Q1 2018 in Review

Delpha Capital Management opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q1 2018: 6,683 shares worth $264K. The stake represents 0.36% of the portfolio and ranks #92 among its holdings.

170 funds tracked by Wall St. Rank hold ARNA as of Q1 2018.

Delpha Capital Management held 6,683 shares of Arena Pharmaceuticals Inc worth $264K as of Q1 2018.
Arena Pharmaceuticals Inc was a new Delpha Capital Management position in Q1 2018.
Arena Pharmaceuticals Inc made up 0.36% of Delpha Capital Management's portfolio in Q1 2018, its #92 holding.
170 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.